Skip to main content

Table 1 MCV4 uptake during 2005 among 11-16 year old adolescents by MCO and age group

From: Uptake of meningococcal conjugate vaccine among adolescents in large managed care organizations, United States, 2005: Demand, supply and seasonality

MCO Local or state MCV4 Legislation§ MCV4 shortage during 2005§ Study Population All adolescents Number (%) Vaccinated Percent Vaccinated by Age Group
       11-12 14-15 13+16
(Ref)
A Yes No 19724 3680 (18.7) 33.7* 13.8* 9.6
B No No 31404 9518 (30.3) 31.9* 32.0* 27.0
C No Yes 13456 1832 (13.6) 15.2* 13.4 12.3
D Unknown Yes 261544 17934 (6.9) 6.4 7.7* 6.4
E Unknown Yes 297761 31308 (10.5) 13.9* 10.3* 7.5
All MCOs -- -- 623889 64272 (10.3) 12.3* 10.5* 8.2
  1. MCV4 - Meningococcal conjugate vaccine
  2. MCO - Managed care organization
  3. §Based on self-report by principal investigator at each MCO
  4. MCO is located in a state with legislation requiring meningococcal vaccination for adolescents in residential schools and postsecondary institutions that provide housing for students.
  5. MCO did not provide a response; however, the state(s) these MCOs are located in did(do) not have any meningococcal vaccination legislation[24].
  6. *p < 0.001 when compared to 13+16 year group